IRIS
BONAVITA, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.806
NA - Nord America 7.173
AS - Asia 6.353
SA - Sud America 1.096
AF - Africa 99
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 29.552
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 9.545
US - Stati Uniti d'America 7.028
SG - Singapore 2.165
CN - Cina 1.477
IT - Italia 1.403
IE - Irlanda 1.397
HK - Hong Kong 986
BR - Brasile 900
VN - Vietnam 733
GB - Regno Unito 596
DE - Germania 513
UA - Ucraina 425
KR - Corea 271
IN - India 210
SE - Svezia 170
FR - Francia 159
TR - Turchia 149
FI - Finlandia 142
JP - Giappone 123
GR - Grecia 121
AT - Austria 104
AR - Argentina 77
MX - Messico 59
CA - Canada 57
BD - Bangladesh 51
NL - Olanda 50
BE - Belgio 40
EC - Ecuador 32
PL - Polonia 30
IQ - Iraq 26
CO - Colombia 25
ES - Italia 24
ID - Indonesia 22
ZA - Sudafrica 22
EG - Egitto 19
PK - Pakistan 19
MA - Marocco 18
VE - Venezuela 18
CZ - Repubblica Ceca 17
AU - Australia 15
SA - Arabia Saudita 14
PY - Paraguay 13
CH - Svizzera 12
IL - Israele 12
CL - Cile 11
IR - Iran 11
PE - Perù 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 9
TN - Tunisia 9
KE - Kenya 8
KZ - Kazakistan 7
LT - Lituania 7
RS - Serbia 7
TH - Thailandia 7
UY - Uruguay 7
DZ - Algeria 6
JM - Giamaica 6
JO - Giordania 6
PA - Panama 6
PH - Filippine 6
RO - Romania 6
AZ - Azerbaigian 5
EU - Europa 5
CR - Costa Rica 4
ET - Etiopia 4
HN - Honduras 4
HR - Croazia 4
IS - Islanda 4
KG - Kirghizistan 4
LU - Lussemburgo 4
MY - Malesia 4
NP - Nepal 4
PT - Portogallo 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
Totale 29.534
Salva come PNG Salva come JPEG
Città #
Moscow 3.362
Dublin 1.395
San Jose 1.087
Hong Kong 968
Santa Clara 916
Singapore 870
Jacksonville 640
Chandler 583
Ashburn 353
Ho Chi Minh City 266
Seoul 265
Hefei 260
Beijing 201
Princeton 201
Dallas 170
Hanoi 168
Ann Arbor 160
Roxbury 159
Medford 147
Bremen 142
New York 134
Bengaluru 127
Boardman 118
Caserta 114
Naples 112
The Dalles 107
Los Angeles 98
Munich 91
Vienna 84
Milan 81
São Paulo 73
Cambridge 71
Wilmington 64
Memphis 63
Rome 63
Woodbridge 56
San Mateo 55
Des Moines 45
Da Nang 44
Nanjing 43
Brussels 39
Norwalk 37
Nuremberg 34
Napoli 33
Orem 33
Jinan 29
Atlanta 27
Redhill 27
Warsaw 27
Belo Horizonte 26
Haiphong 26
San Francisco 25
Shenyang 24
Helsinki 23
London 23
Mexico City 22
Rio de Janeiro 22
Tokyo 22
Brasília 21
Chicago 21
Frankfurt am Main 21
Guangzhou 21
Redwood City 20
Tianjin 20
Denver 19
Stockholm 19
Buffalo 18
Falkenstein 18
Houston 18
Chennai 17
Montreal 17
Brooklyn 16
Phoenix 16
Toronto 15
Aversa 14
Boston 14
Hebei 14
Turin 14
Council Bluffs 13
Curitiba 13
Genoa 13
Hangzhou 13
Lappeenranta 13
Mountain View 13
Nanchang 13
Turku 13
Amsterdam 12
Biên Hòa 12
Campinas 12
Hải Dương 12
Lanzhou 12
Padova 12
Porto Alegre 12
Shanghai 12
Thái Bình 12
Bologna 11
Brno 11
Düsseldorf 11
Johannesburg 11
Manchester 11
Totale 15.075
Salva come PNG Salva come JPEG
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 667
Spazi di Virchow Robin e sclerosi multipla: studio con risonanza magnetica ad Alto Campo 3 Tesla 272
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 211
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 207
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 199
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 194
Advantages of QBI in TBSS analyses. 187
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 181
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 176
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 176
Preliminary data from a study on clinical and neuroradiological correlations between cerebral microbleeds and different subtypes of mild cognitive impairment 176
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 175
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 173
Atypical Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient With Improving Symptoms After Immunocompetence Recovery 172
Telemedicine application to headache: a critical review 169
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. 167
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 167
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 165
Repetitive Transcranial Magnetic Stimulation (rTMS) of Dorsolateral Prefrontal Cortex May Influence Semantic Fluency and Functional Connectivity in Fronto-Parietal Network in Mild Cognitive Impairment (MCI) 163
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 162
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis 158
Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian multi-center study using the Beck Depression Inventory 158
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 158
An exploration of anger phenomenology in multiple sclerosis 157
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 155
Aspetti neuroradiologici inusuali in un caso di leucoencefalite multifocale progressiva in paziente non HIV positivo 152
Is the pathology of posterior cortical atrophy clinically predictable? 151
Long-Term Neuromodulatory Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Plasmatic Matrix Metalloproteinases (MMPs) Levels and Visuospatial Abilities in Mild Cognitive Impairment (MCI) 149
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 149
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 149
Apparently isolated CNS involvement in Erdheim-Chester disease: Case report 148
Il Ruolo della RM nella definizione morfologica dell'invecchiamento cerebrale. 148
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 147
Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS) 147
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 146
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 146
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 144
Chronic acquired hepatocerebral degeneration: a case report. 140
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 140
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications 139
INFRATENTORIAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT TREATED WITH FLUDARABINE AND RITUXIMAB 139
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 139
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 139
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 139
Whole-brain propagation delays in multiple sclerosis, a combined tractography - magnetoencephalography study 138
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 138
Repetitive Transcranial Magnetic Stimulation (rTMS) in Mild Cognitive Impairment: Effects on Cognitive Functions-A Systematic Review 137
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. 137
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 136
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study. 136
e-Health and multiple sclerosis: An update 136
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 136
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 136
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 135
Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project. 135
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 135
The role of diet in multiple sclerosis: A review 132
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 131
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis 130
Apolipoprotein E genotype does not influence the progression of multiple sclerosis 130
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 129
Disability assessment using Google Maps 129
A real-world study of alemtuzumab in a cohort of Italian patients 129
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 128
Anti-GM1 ganglioside antibodies in Parkinson's disease 128
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate 128
Signs and symptoms of COVID-19 in patients with multiple sclerosis 127
Proton spectroscopic imaging - Principles and clinical applications in neurology 127
La terapia della sclerosi multipla 126
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 125
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience 125
Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis 124
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey 124
Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition 124
Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 tesla in the delineation of glioblastomas: Preliminary results 123
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 123
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 123
MAlattie infettive (meningiti, encefaliti, infezione da HIV, encefalopatie spongiformi) 122
Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis 122
Brain atrophy and fatigue in relapsing-remitting multiple sclerosis patients: a 3T study 121
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. 121
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 121
A disease in the age of the web: How to help people with Multiple Sclerosis in social media interaction. 120
Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach. 119
Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report 119
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 119
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity 119
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 119
Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent 118
Social Media and Multiple Sclerosis in the Posttruth Age. 118
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 117
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 117
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. 117
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 116
MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain 116
Assessing disability and relapses in multiple sclerosis on tele-neurology 116
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 116
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 115
Clinical implications for the association of psoriasis and multiple sclerosis: an observational study 115
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 115
Totale 14.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.948
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.457 78 53 37 54 428 45 35 46 62 98 95 426
2022/20232.619 280 51 33 175 314 165 4 162 1.276 29 59 71
2023/20241.486 109 46 87 135 411 116 115 38 32 37 107 253
2024/20254.071 18 37 36 157 643 527 488 336 620 591 361 257
2025/202617.016 608 892 941 810 1.421 8.867 1.066 928 573 396 345 169
2026/202713 13 0 0 0 0 0 0 0 0 0 0 0
Totale 30.047